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Abstract
Background: Strongyloidiasis is one of the most neglected diseases distributed worldwide with endemic areas in developed
countries, where chronic infections are life threatening. Despite its impact, very little is known about the molecular biology
of the parasite involved and its interplay with its hosts. Next generation sequencing technologies now provide unique
opportunities to rapidly address these questions.
Principal Findings: Here we present the first transcriptome of the third larval stage of S. stercoralis using 454 sequencing
coupled with semi-automated bioinformatic analyses. 253,266 raw sequence reads were assembled into 11,250 contiguous
sequences, most of which were novel. 8037 putative proteins were characterized based on homology, gene ontology and/
or biochemical pathways. Comparison of the transcriptome of S. strongyloides with those of other nematodes, including S.
ratti, revealed similarities in transcription of molecules inferred to have key roles in parasite-host interactions. Enzymatic
proteins, like kinases and proteases, were abundant. 1213 putative excretory/secretory proteins were compiled using a new
pipeline which included non-classical secretory proteins. Potential drug targets were also identified.
Conclusions: Overall, the present dataset should provide a solid foundation for future fundamental genomic, proteomic and
metabolomic explorations of S. stercoralis, as well as a basis for applied outcomes, such as the development of novel
methods of intervention against this neglected parasite.
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Introduction
Strongyloidiasis caused by Strongyloides stercoralis is a soil-
transmitted helminthiasis distributed worldwide, affecting more
than 100 million people, with endemic areas in Southeast Asia,
Latin America, sub-Saharan Africa, and parts of the southeastern
United States [1,2]. Recently, it was classified as one of the most
neglected tropical diseases (NTD) [3]. Chronic infections in
endemic areas may be maintained asymptomatically for decades
through the autoinfective cycle with the filariform larvae L3
[1][4,5]. The diagnosis of these chronic infections requires more
sensitive diagnostic methods, particularly in low-level infections
and immunocompromised patients [1].
Epidemiological studies in developed countries have identified
endemic areas where misdiagnosis, inadequate treatment and the
facilitation of hyperinfection syndrome by immunosupression (i.e.
by the administration of steroids) are too frequent and can cause a
high mortality rate ranging from 15 to 87% [5,6]. Among these
areas, an endemic area with chronic patients have been described
at the Valencian Mediterranean coastal region of Spain related to
environmental conditions [7].
The diagnosis of strongyloidiasis is suspected when clinical signs
and symptoms, or eosinophilia is observed [8], but current
definitive diagnosis of strongyloidiasis is usually made on the basis
of detection of larvae in agar plate coproculture and serological
diagnosis by ELISA [9,10]. Those methods have the drawbacks of
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8being time consuming and requiring expertise in the first case, and
of low specificity due to remaining antibodies from previous
infection or cross-reactive antibodies [11]. A recent paper has
described a promising coproantigen ELISA based on a polyclonal
rabbit antiserum raised against excretory/secretory (ES) antigens
from the closely relative Strongyloides ratti [12], but the identification
of S. stercoralis specific ES proteins that could be new potential
targets for diagnosis is still required.
Control of strongyloidiasis has relied mostly on the treatment of
infected individuals with only three anthelmintic drugs: thiaben-
dazole (no longer available), albendazole, and more recently
ivermectin [3,13]. A recent study by Suputtamongkol et al. (2011)
has confirmed that both a single and double dose of oral
ivermectin are more effective than a 7-day course of high dose
albendazole for patients with chronic infection due to S. stercoralis
[14]. The risk of developing genetic resistance against the current
drugs administered (if used excessively and at suboptimal dosages)
exists and is based on the experience with drug resistance in
parasitic nematodes of livestock [15]. Thus, the current focus is on
the discovery of novel drugs against human parasites like S.
stercoralis. Such a discovery effort could be strengthened with an
integrated genomic and bioinformatics approach, using functional
genomic and phenomic information available for the free-living
nematode Caenorhabditis elegans (see WormBase; www.wormbase.
org). This nematode, which is the best characterized metazoan
organism [16,17], is considered to be related to nematodes of the
order Strongylida (to which Strongyloides belong) [18]. Recent
studies have reported that nearly 60% of genes in strongyloides
have orthologues/homologues in C. elegans, with a wide range of
biological pathways being conserved between parasitic nematodes
and C. elegans [19]. The comparison of molecular data sets between
nematodes should therefore allow the identification of specific
biological pathways as potential new targets for nematocidal drugs
[20].
As pointed out recently by Cantacessi et al. (2011) [20], advances
in genomic sequencing like Next Generation Sequencing (NGS)
and annotation as well as the integrated use of ‘-omic’ technologies
are now shedding light on our understanding of the systems
biology of nematodes on an unprecedented scale, and is likely to
provide unique opportunities for the development of entirely new
strategies for the treatment and control of neglected parasitic
diseases. New bioinformatic tools based on robust assembly
protocol for NGS data, along with compilation of a dataset of
experimentally determined ES proteins of parasitic helminths, and
annotation software like KAAS [21], allow efficient and up-to-date
homology-based predictions [22].
To date, there are few molecular and genomic studies on
Strongyloides species, and only the transcriptome from S. ratti adults
has become recently available (http://worm1.liv.ac.uk/file_summary.
html) [23]. In fact, 39166 ESTs are currently available in the NCBI
database of November 2011 (27366 from S. ratti and 11392 from S.
stercoralis). Yoshida et al. (2011) have obtained 162 unique singletons
and contigs from S. venezuelensis [24], and a recent study by
Ramanathan et al. (2011) has described DNA microarray for S.
stercoralis and used them to compare infective third-stage larvae
(L3i) with non-infective first stage larvae (L1), with 935 differen-
tially expressed genes identified [25].
In the present study, we have explored and functional annotated
the transcriptome of L3i of S. stercoralis by 454 sequencing coupled
to semi-automated bioinformatic analyses and predicted potential
therapeutic targets for strongyloidiasis.
Materials and Methods
Accession numbers
The nucleotide sequence data obtained for this study are
available in the GenBank database under accession number
ERP000798.
The assembled data from this study can be requested from the
corresponding author.
Parasite material and ethical issues
Fecal samples were obtained at the Hospital La Ribera, Alzira,
Valencia (Spain) from an infected individual in compliance with
Spanish ethical regulations [7], and approved by the Ethics
Committee in human research from the Universitat de Valencia.
Oral consent from the patient was obtained (she was happy to
participate in the study but felt uncomfortable with signing a
form), and documented as a tick on the case record form following
the Hospital Reviewing Board protocols. Samples were cultured
on Agar Petri dishes and L3i larvae were harvested and
concentrated by centrifugation for 5 min at 1000 g, washed three
times in 1 ml of phosphate buffered saline (PBS) pH 7.2
containing protease inhibitors (10 mM EDTA, and 1 mM PMSF)
and samples were processed for RNA isolation.
RNA isolation, cDNA synthesis and 454 sequencing
Total RNA from around 500 larvae was prepared using
Vantage
TM Total RNA purification kit (Marligen Biosciences,
Ijamsville, MD, USA) following the manufacturers’ instructions
and treated with Ambion DNA-free
TM DNase (Ambion/Applied
Biosystems, Austin, TX). The integrity of the RNA was verified by
gel electrophoresis and the yield determined using the nanoDrop
ND-1000 UV-VIS spectrophotometer v.3.2.1 (NanoDrop Tech-
nologies, Wilmington, DE).
The cDNA library was constructed from 0.5 mg total RNA
using MINT cDNA Synthesis Kit (Cat#SK001, Evrogen). First
strand cDNA synthesis starts from 39-primer comprising oligo(dT)
to enrich mRNA as template. Double strand cDNA synthesis was
performed using 17 cycles of PCR amplification. Total cDNA was
Author Summary
Strongyloides stercoralis (Nematoda) is an important
parasite of humans, causing Strongyloidiasis, considered
as one of the most neglected diseases, affecting more than
100 million people worldwide. Chronic infections in
endemic areas can be maintained for decades through
the autoinfective cycle with the L3 filariform larvae. In
these areas, misdiagnosis, inadequate treatment and the
facilitation of hyperinfection syndrome by immunosupres-
sion are frequent and contribute to a high mortality rate.
Among the affected areas, chronic patients have been
described in the Valencian Mediterranean coastal region of
Spain. Despite its serious impact, very little is known about
this parasite and its relationship with its hosts at the
molecular level, and more effective diagnostic tests and
treatments are needed. Next generation sequencing
technologies now provide unique opportunities to rapidly
advance in these areas. In this study, we present the first
transcriptome of S. stercoralis L3i using 454 sequencing
followed by semi-automated bioinformatic analyses. Our
study identifies 8037 putative proteins based on homol-
ogy, gene ontology, and/or biochemical pathways, includ-
ing putative excretory/secretory proteins as well as
potential drug targets. The present dataset provides a
useful resource and adds greatly to our understanding of a
human parasite affecting both developed and developing
countries.
S. stercoralis L3i Transcriptome
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tails. cDNA obtained was used to perform a library with the
required sequencing adaptors and was then sequenced using the
Genome Sequencer (GS) FLX instrument (Roche Diagnostics)
[26].
Bioinformatic analyses of sequence data
The overall bioinformatics analysis strategy followed was as
described originally by Nagaraj et al. [27,28], implemented in the
analysis pipelines ESTExplorer [29] and EST2Secretome [28].
This workflow approach has been successfully used for the analysis
of transcriptomic data from Dictyocaulus viviparus [30], Fasciola
hepatica [31], Clonorchis sinensis [32] and Opisthorchis viverrini [32].
However, to better identify non-classically secreted proteins from
helminth parasites [33,34], we have recently implemented a novel
analysis strategy for short reads applied on Strongyloides ratti [22]
(see Figure S1).
FASTA and associated quality files were extracted from the SFF
file after removing the sequence adapters. These reads were
preprocessed and their contigs were assembled using MIRA v.3.2
(http://chevreux.org/projects_mira.html) [35] with the following
parameters:
-job=denovo,est,accurate,454 -fasta
-OUT:rrol=1:rld=1:orc=1:org=0:ora=0:ors=0:otf=0:otc=
0 -GE:not=1 -CO:asir=1
-LR:mxti=1 -AS:sd=0:uess=0:urd=0:ard=1 -SK:mmhr=
2:mnr=yes 454_SETTINGS
-DP:ure=0 -CO:mrpg=10 -AS:bdq=40
-CL:pvlc=0:cpat=0:mbc=1:mbcgs=30:mbcmfg=30:mbcmeg=
30:qc=0 -ED:ace=1
-AL:egp=no
-ALIGN:bip=20:bmax=120:mo=10.
Contigs generated from MIRA were aligned and reassembled
into second order contigs using the Contig Assembly Program v.3
(CAP3) [36], employing a minimum sequence overlap length cut-
off of 40 bases and an identity threshold of 90%. Following the
assembly of S. stercoralis reads into second order contigs by CAP3
and contigs by MIRA, this contig dataset was matched using
BLASTX with the NCBI non-redundant sequence database;
http://www.ncbi.nlm.nih.gov, BLASTN with Nematode.net S.
stercoralis ESTs (www.nematode.net/) and BLASTN with dbEST
Strongyloides ESTs (www.ncbi.nlm.nih.gov/dbEST/), using permis-
sive (E-value: ,1E
205), moderate (,1E
215) and/or stringent
(,1E
230) search strategies.
S. stercoralis contigs were conceptually translated into putative
proteins using the program ESTScan [37]. Putative protein
sequences were subjected to secretome analysis using TMHMM (a
membrane topology prediction program) [38] to predict trans-
membrane domains, SignalP 3.0 (signal peptide prediction
program) [39], SecretomeP (a prediction programme used to
identify non-classical secretory proteins in mammals [40], but used
in the case of parasitic helminths as well [41]), and TargetP
(mitochondrial protein prediction program) [42]. Briefly, excreto-
ry/secretory (ES) proteins were selected based on the presence of a
signal peptide at the N-terminus using SignalP 3.0 (employing
both the neural network and hidden Markov models) or predicted
as secretory using SecretomeP, predicted as non-mitochondrial by
TargetP and absence of transmembrane domains. In addition to
computational prediction of ES proteins were identified and
collated based on sequence homology (BLASTP, E-value,1E
215)
to known ES proteins found in parasitic helminths secretome
studies.
Putative proteins were classified functionally using InterProScan
[43], employing the default search parameters. Based on their
homology to conserved domains and protein families, predicted
proteins were classified into Gene Ontology (GO) categories
(http://www.geneontology.org/) based on molecular function,
cellular component and biological process using interpro terms.
Putative proteins were also subjected to pathway analysis, utilizing
KEGG-Automatic Annotation Server (KAAS) [21], which maps
the putative proteins to biochemical pathways in which they are
involved and categories of Brite objects like enzymes, transcription
factors and translation factors.
Putative proteins were subjected to BLAST2GO software to
identify homologues from the most abundant ES transcripts [44].
BLASTP (Wormpep v 224) was used to identify C. elegans known
proteins homologues present in S. stercoralis proteins using
moderate search strategy (E-value: ,1E
215). These proteins were
also searched for sequence homology (BLASTP, E-value,1E
205)
in human (host) proteins. All the proteins which were found
homologous to C. elegans proteins and non-homologous to human
proteins were mapped to C. elegans RNAi phenotypes and known
drug targets present in the DrugBank database (http://drugbank.
ca/), a unique bioinformatics and cheminformatics resource that
combines detailed drug (i.e. chemical, pharmacological and
pharmaceutical) data with comprehensive drug target (i.e.
sequence, structure, and pathway) information [45].
Results
The transcriptome of S. stercoralis L3i larvae
Initially a total of 253266 short reads (82490223 bases) were
generated with 3256132.4 bases (average length 6 standard
deviation), with a GC content of 31.84%. These short reads were
pre-processed, which resulted in 237341 (93.7%) quality short reads
(EBI Sequence Read Archive [SRA] accession ID ERP000798).
High quality reads were assembled into 12333 contigs using MIRA
as described in the pipeline (Figure S1). Using CAP3, we were able
to achieve 507 second order contigs, leaving 10845 MIRA contigs
not assembled further by CAP3. We considered 11250 (99.1%)
contigs with a minimum length of 90 bases, discarding sequences
yielding peptides ,30 amino acids, for further secretory protein
prediction and analysis. These contigs were conceptually translated
into 8037 proteins by ESTScan (Table 1; sequences available from
http://biolinux.uv.es/marcilla/).
Putative proteins were annotated based on protein families and
domains using Interproscan and mapped to biochemical pathways
using KAAS [21]. Of the 8037 putative proteins, we were able to
annotate 4494 (55.91%) proteins with protein domains and
Table 1. Expressed sequence tag (EST) data for the S.
stercoralis L3i.
No. of EST Clusters by MIRA 12,333
Average length (6standard deviation) 538.7 (6260.7)
Re clustered unigenes after CAP3 assembly 11,352
Containing an Open Reading Frame 8,037
Returning InterProScan results 4,494
Gene Ontology 3,534
Biological process 1,905
Cellular component 1,068
Molecular function 3,083
Prediction of biological pathways (KAAS) 1,559
doi:10.1371/journal.pntd.0001513.t001
S. stercoralis L3i Transcriptome
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in Table S1.
A total of 3534 proteins were annotated with GO terms (3083
{Molecular Function}, 1068 {Cellular Component} and 1905
{Biological Process}) based on Interpro term annotations (Tables 1
and S1). We established pathway associations for 1559 (19.39%)
putative proteins (Table 1).
All the contigs generated by using MIRA+CAP3were checkedfor
homologous proteins against the non-redundant nucleotide database
(NR-NCBI), existing Strongyloides expressed sequence tags (ESTs)
present in dbEST, S. stercoralis ESTs available from dbEST and
nematode.net, S. ratti cDNA sequencing data from the University of
Liverpool (available at http://worm1.liv.ac.uk/file_summary.html),
and also for homologous proteins in C. elegans and human data
(Figure S1). Similarity searches were done using using BlastX and
BlastP algorithms at different E values (Table 2). A total of 3412
(42.45%) S. stercoralis putative proteins had homologues in the free-
living nematode, Caenorhabditis elegans using stringent match condi-
tions (E value: ,1E
215). The recent availability of S. ratti
transcriptome data prompted us to compare these with our data
and 3855 similar putative proteins (47.96%) were found. As S.
stercoralis infects humans, we checked the similarity of S. stercoralis
proteins with known human proteins using BlastP at different E
values. Our results showed that 3759 putative proteins were similar
to human ones using a permissive searchstrategy (E-value: ,1E
205),
discarding them as potential targets for treatment (Table 2).
Predicted proteins were also categorized according to their
inferred molecular function, cellular localization and association
with biological pathways. Mapping to KEGG BRITE objects [46]
is shown in Table 3. Enzymes were by far the most abundant
category, with 720 putative proteins, followed by chromosome,
spliceosome and ribosome components (with 90, 89 and 73
putative proteins, respectively). 73 putative protein kinases and 72
peptidases were also identified by BRITE (Table 3). These 72
peptidases corresponded to 60 different enzymes from 9 groups,
including calpains, cathepsins, different proteasome components
and aminopeptidases, and other ‘‘nematode common’’ proteases
such as astacin, legumain, and insulysin (Table S2).
All the putative proteins were grouped according to KEGG
pathways [46] into five categories, with metabolic proteins being
the most abundant, followed by genetic information processing,
environmental processing and cellular processes (Table 4). In the
first group, the most abundant putative proteins were related to
carbohydrate metabolism (201 proteins, 2.5%), amino acid
metabolism (174; 2.16%) and lipid metabolism (104; 1.29%). Also
23 putative proteins were related to drug metabolism (Table 4). In
the second group, the most abundant proteins were related to
translation (195; 2.42%), meanwhile 144 putative proteins (1.79%)
related to signal transduction were the most abundant in the group
of cellular processes (Table 4).
Prediction of ES proteins
We next analyzed ES proteins, which are key molecules to
understand host-parasite interactions [47]. Molecules from the
secretome contribute to important processes like parasite feeding,
tissue penetration or larval migration, and could participate in
blocking and/or evading host immune responses [48]. ES
prediction was carried out in Phase III of the pipeline (Fig. S1).
Firstly, 247 (3.07%) proteins were predicted as classical secreted
proteins using SignalP [39]. The remaining 7785 (96.86%)
proteins, which were predicted as non-secretory by SignalP were
processed by SecretomeP [40] for prediction of non-classical
secretory proteins, with 252 (3.14%) proteins identified here. The
classical and non-classical secretory proteins (499, 6.21%) from
these two programs were analyzed by TargetP [42] for
mitochondrial proteins. Only 7 proteins were predicted as
mitochondrial proteins using TargetP at 95% specificity. These
seven proteins were removed from the set of 499 secreted proteins,
with 492 secretory proteins passed to TMHMM [38] for the
prediction of transmembrane proteins. 161 (2%) proteins, were
predicted as transmembrane proteins having one or more
transmembrane helices, and removed from the secretory protein
dataset. A total of 331 (4.12%) proteins were finally predicted as
ES proteins from the computational prediction pipeline. Proteins
that were considered non-secretory by SecretomeP and SignalP
were matched to our in-house dataset of 1080 non redundant
experimentally determined parasitic helminth proteins [22] using
the BLASTP [49] similarity search. We found an additional 882
(10.97%) putative proteins similar to known ES proteins by this
homology search approach (E value: ,1E
215) (Table S3). From
those proteins, 50 have been recently described in the ES from
infective larvae of the related species S. ratti [50] (data not shown).
Among the most abundant transcripts encoding ES proteins
appeared a major antigen; cytoskeletal proteins like myosin heavy
chain, troponin, tropomyosin, actin; galectins; enzymes like
trehalase, PEPCK, GAPDH, enolase, as well as phosphatases
and kinases; proteases like Metalloproteinase, Calpain-1and
Cathepsin L; stress proteins like HSPs; calcium binding proteins;
detoxifying enzymes along with elongation factors, histones,
ubiquitins and signaling molecules (Table S4. Thus, for annotation
and analyses in Phase III, we compiled a total of 1213 ES proteins,
which is 15.09% of our putative proteins.
S. stercoralis proteins as drug targets
We found 4234 (52.68%) S. stercoralis putative proteins which
had no homologues present in humans (Table 2) and therefore are
Table 2. Sequence homology inferred between S. stercoralis current dataset and other datasets.
Dataset Hits (1e-05) Hits (1e-15) Hits (1e-30)
Strongyloides EST from dbEST (BLASTN) 4267 3935 3646
S. stercoralis EST from dbEST (BLASTN) 2903 2682 2519
S. stercoralis EST from nematode.net (BLASTN) 2225 2020 1904
S. ratti putative proteins (BLASTP) 3855 3052 2081
C. elegans proteins (BLASTP) 4475 3,412 2163
Human proteins (BLASTP) 3759 2583 1489
NR database (BLASTX) 7633 5948 4023
doi:10.1371/journal.pntd.0001513.t002
S. stercoralis L3i Transcriptome
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dissimilar proteins of S. stercoralis were checked for known drug
targets, which have lethal RNAi phenotypes present in C. elegans,
not present in human and similar to known drug targets, data
available from DrugBank 3.0 database [44], a unique bioinfor-
matics and cheminformatics resource that combines detailed drug
(i.e. chemical, pharmacological and pharmaceutical) data with
comprehensive drug target (i.e. sequence, structure, and pathway)
information. The database (available at http://drugbank.ca/)
contains 6707 drug entries (as of November 2011).
We found 14 contigs and singletons corresponding to four
different proteins. These could represent potential therapeutic
targets for strongyloidiasis as shown in Table 5. Sequence
comparison demonstrate that these proteins are homologous to
2,3-bisphosphoglycerate independent phosphoglycerate mutase
from Ascaris suum (with 1 contig and 1 singleton), hypothetical
protein CBG01975 from Caenorhabditis briggsae similar to glutamate
synthase [NADPH] from Ascaris suum (1 contig and 3 singletons),
isocitrate lyase from S. stercoralis (5 singletons), and alcohol
dehydrogenase I from the fungus Candida albicans WO-1 (2
singletons) (Table 5).
With a comparative analysis searching protein domain mapping
or sequence similarity with other drug targets, we found seven
additional potential targets for treatment, including well known
drug targets as tubulin b, c-amino butyric acid A (GABA)
receptor, glutamate-gated chloride channel or GST (Table S5).
Only one of those proteins, homologous to Ancylostoma caninum
metalloprotease precursor, which is also predicted to be secretory,
was not found similar either to C. elegans or human proteins (Table
S5).
Discussion
Strongyloides stercoralis can replicate within the host (autoinfection)
allowing the infection to remain undiagnosed and untreated for
years, resulting in perpetuating parasite dispersal, increasing the
risk of infection and eventually the appearance of resistances [3].
Uncontrolled multiplication of the parasite (hyperinfection) can be
life-threatening in immunocompromised individuals. We also face
serious endemic recurring infections in the future if this infection is
not controlled in transition economies like China, India, Southeast
Asia and Latin America [3] where the use of immunosuppressive
therapy is becoming common. As pointed out by Olsen et al. (2009)
[3], there is an urgent need to employ modern molecular methods
to improve and simplify diagnosis, differentiate species and strains
to facilitate epidemiological studies of S. stercoralis.
The present study provides the first detailed analysis of the
transcriptome of the human pathogenic S. stercoralis L3i larvae and
has identified specific molecules predicted to play key biological
functions in this parasite. A total of 12,333 contigs were inferred
from the present EST dataset, thus increasing the number of
predicted proteins currently available (for this stage/species) in
public databases by approximately 141-fold [we obtained 8037
conceptually translated proteins, and there are currently 57
proteins in Genbank as of November 2011]. This quantity of
contigs is similar to the numbers obtained with other nematodes
like Trichostrongylus colubriformis [19], N. americanus and Ancylostoma
caninum [51], Haemonchus contortus [52], Dictyocaulus viviparous [20],
and Teladorsagia circumcinta [53]. The subset (55.91%) of S. stercoralis
sequences with orthologues/homologues in public databases was
slightly higher to that reported in similar transcriptomic studies of
other animal-parasitic helminths such as Necator americanus [51,54].
It is noteworthy to mention that 44.09% of the putative proteins of
S. stercoralis L3i transcriptome remain unannotated, warranting
further genomic and functional characterization studies.
With the exception of three metabolic proteins (citrate synthase,
arginine kinase and ATP:guanido phosphotransferase) all proteins
identified in a previous proteomic study with S. stercoralis L3i [55]
were included in the transcriptome described here. In addition, 41
antigenic proteins including SiR and tropomyosin were present in
the transcriptome (as searched in Table S1), confirming its value as
a tool for searching targets for immunodiagnosis.
It is well characterized that upon infection, infective larvae (L3i)
must penetrate skin as quickly as possible and then migrate within
the host. In this context, proteases play an essential role. Among
the proteins identified in our study, 60 different putative proteases
were annotated in nine groups. These include nine metallopro-
teinases and three aspartic proteases, some of them assumed to
play a major role in skin penetration in Strongyloides stercoralis
[56,57], and in other Strongyloides species like S. venezuelensis [58] or
Table 3. Functions of putative proteins inferred from the
transcriptome of the S. stercoralis L3i.
BRITE object name
Number of putative
proteins mapped
Enzymes 720
Chromosome 90
Spliceosome 89
Ribosome biogenesis 73
Protein kinases 73
Peptidases 72
Ubiquitin system 72
Ribosome 72
Chaperones and folding catalysts 61
Cytoskeleton proteins 53
Proteasome 41
Ion Channels 38
Transcription factors 36
Translation factors 34
DNA repair and recombination proteins 32
GTP-binding proteins 25
DNA replication proteins 20
Glycosyltransferases 15
Lipid biosynthesis proteins 14
Cellular antigens 11
Transporters 11
Secretion system proteins 10
Glycan binding proteins 9
SNAREs 7
Nuclear receptors 6
Prenyltransferases 6
G protein coupled receptors 4
CAM ligands 4
Proteoglycans 4
Enzyme linked receptors 2
Cytokine receptors 2
Cell adhesion molecules (CAMs) 2
Bacterial toxins 1
doi:10.1371/journal.pntd.0001513.t003
S. stercoralis L3i Transcriptome
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recently identified an astacin-like metalloproteinase as being
specific of L3i in a transcriptomic study. Another abundant group
was the cysteine proteases, including cathepsin B, legumain and
calpain, proteins characterized as immunomodulators of host
response and promising vaccine and drug targets [59–61]. Similar
results have been reported for Ascaris suum, where 456 peptidases
have been identified in its draft genome [62].
Kinases are also an important group of proteins considered to
be good druggable targets from the medical and chemical
viewpoints, since they play essential functions in the parasite, in
mediating signal transduction [63–65]. In S. stercoralis L3i
transcriptome analysis 73 putative kinases including 11 putative
tyrosine kinases were identified (Table 3 and Table S1).
In our study, we have compiled 1213 putative ES proteins
among the 8037 (15.09%) S. stercoralis annotated proteins using a
new semi-automated computational approach, recently developed
and applied to predict the secretome of S. ratti adults [22]. In a
mixture of S. ratti parasitic females, free-living males and free-living
females, Garg and Ranganathan (2011) compiled 2572 putative
ES proteins, being 12.3% of the total putative proteins, which is
less than that found in S. stercoralis L3i larvae [22]. This could be
due to higher secretion processes in larvae in comparison to adults,
required by penetration and migration in the host. Supporting this
notion, Soblik et al. (in press) have recently described the presence
of 586 ES proteins in all the stages of S. ratti by proteomic analysis,
196 of which are also found in L3i [50]. When comparing larval S.
ratti ES proteins with our predicted S. stercoralis L3i ES proteins, we
find that 50 out of the 196 proteins identified from S. ratti were also
detected in S. stercoralis L3i, supporting the value of the prediction.
In S. stercoralis L3i, the most abundant transcripts encoding ES
proteins include cytoskeletal proteins (i.e. myosin heavy chain,
actin, tropomyosin, tubulin or paramyosin), metabolic enzymes
(i.e. Trehalase, PEPCK, PGK, PGM, GAPDH, enolase), prote-
ases, stress-response proteins, detoxifying enzymes, proteaseome
components, most of them identified previously in S. stercoralis by
proteomic studies [55]. These ES proteins play a major role in
infection since they are present at the host-parasite interface and
regulate host immune system [66]. ESPs also are among the target
choice of new therapeutic solutions for helminth infections [67], as
confirmed in the case of ivermectin (the currently the drug of
choice for treating strongyloidosis) which has been shown to act
reducing the secretion of ESPs from the ES apparatus in Brugia
malayi microfilariae [68].
Recent studies using microarrays have identified highly
expressed molecules in S. stercoralis L3i in comparison to L1
Table 4. KEGG pathways of putative proteins inferred from the transcriptome of S. stercoralis L3i.
Parent KEGG pathway No of putative proteins (%) Top KEGG pathway in the category
Metabolism
Carbohydrate metabolism 201 (2.50) Glycolysis/Gluconeogenesis
Energy metabolism 79 (0.98) Oxidative phosphorylation
Lipid metabolism 104 (1.29) Fatty acid metabolism
Nucleotide metabolism 100 (1.24) Purine metabolism
Amino acid metabolism 174 (2.16) Valine, leucine and isoleucine degradation
Metabolism of other amino acids 48 (0.60) Glutathione metabolism
Glycan biosynthesis and metabolism 30 (0.37) N-Glycan biosynthesis
Metabolism of Cofactors and Vitamins 46 (0.57) One carbon pool by folate
Metabolism of Terpenoids and Polyketides 5 Terpenoid backbone biosynthesis
Biosynthesis of other secondary metabolites 1 Caffeine metabolism
Xenobiotic biodegradation and metabolism 23 (0.29) Drug metabolism – other enzymes
Genetic Information processing
Transcription 83 (1.03) Spliceosome
Translation 195 (2.42) Ribosome
Folding, sorting and degradation 178 (2.21) Protein processing in endoplasmic reticulum
Replication and repair 34 (0.42) Nucleotide excision repair
Environmental information processing
Membrane transport 3 ABC transporters
Signal transduction 144 (1.79) MAPK signaling pathway
Signaling, molecules and interaction 7 Neuroactive ligand-receptor interaction
Cellular processes
Transport and catabolism 132 (1.64) Endocytosis
Organism systems
Immune system 7 Natural killer cell mediated cytotoxicity
Endocrine system 11 (0.13) Progesterone-mediated oocyte maturation
Development 3 Dorso-ventral axis formation
Environmental adaptation 6 Circadian rhythm – mammal
doi:10.1371/journal.pntd.0001513.t004
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potentially constitute new targets for intervention [25], all of which
were present in our transcriptome data, but did not appear as
druggable targets following our pipeline, possibly as these are not
present in DrugBank, where only lethal RNAi phenotypes are
included. Other important targets if interfered with, would still
lead to expulsion of live worms form a host, like motility genes. In
agreement with this, Garg and Ranganathan (2011) [22] have
recently identified 19 contigs as putative drug targets in the S. ratti
adult transcriptome, including myosin heavy chain, which is also
one of the most abundant transcript of ES proteins in S. stercoralis
(Table S4). This protein along with others like a metalloproteinase
precursor, major sperm protein or triosephosphate isomerase (also
identified in the S. stercoralis transcriptome in our study) did not
appear as druggable molecules in our study, due to the presence of
these proteins in host cells as well. In this context, efficient drugs as
antihelmintics like benzimidazoles (they inhibit tubulin ß resulting
in impaired microtubule formation during cell division) have much
more affinity for tubulin in helminth cells than the tubulin found in
the cells of mammals [69]. We found 11 potential targets for
treatment against L3i larvae. As already mentioned, these are the
first evolutive phase of S. stercoralis in the host, and constitute a
good target for treatment. From these target molecules, four, with
no homologues in the host, suggesting parasite specificity, are: 2,3-
bisphosphoglycerate independent phosphoglycerate mutase, glu-
tamate synthase, isocitrate lyase and alcohol dehydrogenase I.
Only the first one was predicted as present in ES. Further studies
are required to confirm whether these molecules are good drug
targets for strongyloidiasis. Next-generation sequencing technolo-
gies are improving genomic and transcriptomic studies, and
complemented by proteomic investigations, should allow the
characterization of differential gene expression and essential
pathways in all the developmental stages of S. stercoralis. The
transcriptomic dataset described here constitutes the basis for
future investigations enlightening the search for control measures
for one of the most neglected diseases.
Supporting Information
Figure S1 Bioinformatics workflow used for transcrip-
tomic data analysis. Bioinformatics workflow comprising
Phase I (pre-processing and assembly), II (Nucleotide level
annotation), III (prediction of excretory/secretory (ES) proteins)
and IV (Protein-level annotation).
(DOC)
Table S1 Strongyloides stercoralis L3i gene ontology
mapping using Interproscan.
(XLS)
Table S2 Peptidases found in the S. stercoralis L3i
transcriptome.
(XLS)
Table S3 BLAST results of proteins found homologous
to experimentally verified secretory proteins of parasit-
ic helminths at 1e-
15.
(XLS)
Table 5. Predicted therapeutic targets from S. stercoralis L3i.
No Cluster ID
Description from
NR Database
WBGene
ID
C. elegans RNAi
lethal phenotype
Interpro
hits C. elegans Gene Ontology
Drugbank targets
hits ESP
1 Contig 19
Singleton
1215
2,3-
Bisphosphoglycerate
independent
phosphoglycerate
mutase (Ascaris suum)
WBGene
00019001
Slow growth;
embryonic lethal;
larval arrest; organism
morphology abnormal;
e g gl a y i n ga b n o r m a l ;
locomotion abnormal;
life span abnormal
IPR006124
IPR017850
BIOLOGICAL PROCESSES: glucose
catabolic process; positive regulation
of growth rate; embryonic development
ending in birth or egg hatching;
nematode larval development; body
morphogenesis; locomotion;
determination of adult life span;
oviposition. MOLECULAR FUNCTION:
phosphoglycerate mutase CELLULAR
COMPONENT: cytoplasm
2,3-
Bisphosphoglycerate
independent
phosphoglycerate
mutase
yes
2 Contig 462
Singletons
600, 2555,
3841
Hypothetical protein
CBG01975
(Caenorhabditis briggsae)
Glutamate synthase
[NADPH] (Ascaris suum)
WBGene
00012326
Slow growth;
embryonic lethal;
larval arrest
IPR000583
IPR002932
IPR017932
IPR002489
BIOLOGICAL PROCESSES: electron
transport; glutamate biosynthetic process;
nitrogen compound metabolic process;
embryonic development ending in birth
or egg hatching; nematode larval
development; positive regulation of
growth rate. MOLECULAR FUNCTION:
oxidoreductase activity, acting on the
CH-NH2 group of donors, NAD or NADP
as acceptor FAD binding; glutamate
synthase activity, NADH or NADPH as
acceptor; iron-sulfur cluster binding
Ferredoxin-dependent
glutamate synthase 2
No
3 Singletons
77, 154,
179, 2466,
10457
Isocitrate lyase
(Strongyloides stercoralis)
WBGene
00001564
Life span abnormal IPR000918
IPR006254
IPR015813
BIOLOGICAL PROCESSES: glyoxylate
cycle; carboxylic acid metabolic process;
embryonic development; determination
of adult life span. MOLECULAR
FUNCTION: isocitrate lyase activity;
malate synthase activity
Isocitrate lyase No
4 Singletons
2046,
10787
Alcohol dehydrogenase
I( Candida albicans
WO-1)
WBGene
00010790
Life span abnormal IPR002085
IPR011032
IPR013149
BIOLOGICAL PROCESSES: metabolic
process determination of adult life
span MOLECULAR FUNCTION: zinc
ion binding oxidoreductase activity
Alcohol
dehydrogenase
No
Putative proteins homologous to C. elegans proteins with lethal RNAi phenotype and with no homologue in the human host.
doi:10.1371/journal.pntd.0001513.t005
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loides stercoralis L3i excretory/secretory proteins using
Blast2Go [44].
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Table S5 S. stercoralis L3i putative proteins found
similar to known therapeutic targets in parasitic
nematodes either by protein domains mapping or
sequence similarity.
(DOCX)
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